JP2024547022A - 一酸化窒素放出性鼻腔用組成物及び、それを使用する方法 - Google Patents

一酸化窒素放出性鼻腔用組成物及び、それを使用する方法 Download PDF

Info

Publication number
JP2024547022A
JP2024547022A JP2024536373A JP2024536373A JP2024547022A JP 2024547022 A JP2024547022 A JP 2024547022A JP 2024536373 A JP2024536373 A JP 2024536373A JP 2024536373 A JP2024536373 A JP 2024536373A JP 2024547022 A JP2024547022 A JP 2024547022A
Authority
JP
Japan
Prior art keywords
composition
nitric oxide
optionally
citric acid
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024536373A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024547022A5 (https=
Inventor
リッチオ,ダニエル,アルバート
ギア,キャリー,ブロドナックス
プリヴェット,ベンジャミン,ジョセフ,モンロー
ウォルター,シェイリン,エリザベス
Original Assignee
エルエヌエイチシー,インク.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エルエヌエイチシー,インク. filed Critical エルエヌエイチシー,インク.
Publication of JP2024547022A publication Critical patent/JP2024547022A/ja
Publication of JP2024547022A5 publication Critical patent/JP2024547022A5/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/04Nitro compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2024536373A 2021-12-17 2022-12-16 一酸化窒素放出性鼻腔用組成物及び、それを使用する方法 Pending JP2024547022A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163290928P 2021-12-17 2021-12-17
US63/290,928 2021-12-17
PCT/US2022/081754 WO2023114971A1 (en) 2021-12-17 2022-12-16 Nitric oxide-releasing nasal compositions and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2024547022A true JP2024547022A (ja) 2024-12-26
JP2024547022A5 JP2024547022A5 (https=) 2025-12-09

Family

ID=86773604

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024536373A Pending JP2024547022A (ja) 2021-12-17 2022-12-16 一酸化窒素放出性鼻腔用組成物及び、それを使用する方法

Country Status (9)

Country Link
US (1) US20250049841A1 (https=)
EP (1) EP4447946A4 (https=)
JP (1) JP2024547022A (https=)
KR (1) KR20240125633A (https=)
CN (1) CN118742298A (https=)
AU (1) AU2022409833A1 (https=)
CA (1) CA3240044A1 (https=)
IL (1) IL313526A (https=)
WO (1) WO2023114971A1 (https=)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1871433B1 (en) * 2005-03-24 2009-04-22 NOLabs AB Cosmetic treatment with nitric oxide, device for performing said treatment and manufacturing method therefor
EP1888510A4 (en) * 2005-05-27 2013-01-16 Univ North Carolina NITROGEN OXIDE-RELATED PARTICLES FOR NITROGEN OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS
WO2010044875A2 (en) * 2008-10-16 2010-04-22 Novan, Inc. Nitric oxide releasing particles for oral care applications
AU2015229626B2 (en) * 2014-03-14 2021-05-20 Sanotize Research And Development Corp. Treating diseases using nitric oxide releasing solutions
WO2016160089A1 (en) * 2015-03-27 2016-10-06 Novan, Inc. Topical antiviral compositions, delivery systems, and methods of using the same
EP3177262A4 (en) * 2014-08-08 2018-04-18 Novan Inc. Topical emulsions
US11166980B2 (en) * 2016-04-13 2021-11-09 Novan, Inc. Compositions, systems, kits, and methods for treating an infection
GB2599818B (en) * 2019-06-04 2024-01-31 Thirty Respiratory Ltd Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
CN112791096A (zh) * 2020-12-31 2021-05-14 南京诺令生物科技有限公司 一种可自提供一氧化氮的洗鼻盐及其应用

Also Published As

Publication number Publication date
EP4447946A4 (en) 2026-01-07
IL313526A (en) 2024-08-01
AU2022409833A1 (en) 2024-06-20
WO2023114971A1 (en) 2023-06-22
US20250049841A1 (en) 2025-02-13
CA3240044A1 (en) 2023-06-22
EP4447946A1 (en) 2024-10-23
CN118742298A (zh) 2024-10-01
KR20240125633A (ko) 2024-08-19

Similar Documents

Publication Publication Date Title
JP6651499B2 (ja) 局所用抗ウイルス薬組成物及びこれを使用する方法
JP6899845B2 (ja) 感染症を治療するための組成物、システム、キットおよび方法
US20260090992A1 (en) Compositions and applications thereof
US20170196904A1 (en) Silicone oil-containing formulations for nasal application
AU2017273508A1 (en) Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof
US20220096536A1 (en) THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES
TW202227104A (zh) 預防感染之組合物
CN116018130A (zh) 含儿茶素的组合物和用途
JP2024547022A (ja) 一酸化窒素放出性鼻腔用組成物及び、それを使用する方法
US11642372B2 (en) Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
JP2024128022A (ja) 微生物感染を消毒、処置および予防するための組成物および方法
US20250352558A1 (en) Water-soluble cannabidiol compositions and method for preparation of water-soluble cannabidiol
CN113244262A (zh) 一种用于预防及治疗呼吸道感染性疾病的吸入粉雾制剂
WO2021191904A1 (en) Methods for preventing and treating viral infection
US12042514B2 (en) Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
CN1909894B (zh) 药物组合物
WO2023021329A1 (en) Compositions and methods to disinfect, treat and prevent microbial infections
AU2022410715B2 (en) Pharmaceutical combination for the treatment of the respiratory infection caused by sars-cov-2
CN117083057A (zh) 用于预防感染的组合物
US11986516B2 (en) Compositions and methods for treatment of SARS-COV-2
CN102369012B (zh) 氧化氘用于治疗病毒性呼吸道疾病的用途
HK40068775B (zh) 法匹拉韦在制备预防或治疗冠状病毒感染性疾病药物中的应用
US20240091253A1 (en) THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES
CN113244263A (zh) 一种用于预防及治疗呼吸道感染性疾病的雾化吸入制剂
CN114159442A (zh) 法匹拉韦在制备预防或治疗冠状病毒感染性疾病药物中的应用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251201

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251201